Jul 15 (Reuters)-
Chordia Therapeutics Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
May 31, 2026 May 31, 2025 Aug 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 1.07 loss 1.42 loss 2.01
Recurring loss 1.05 loss 1.40 loss 1.96
Net loss 1.05 loss 1.40 loss 1.96
EPS loss 14.45 yen loss 20.43 yen loss 28.41 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Chordia Therapeutics Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=190A.T